The natriuretic peptides in cardiovascular medicine

VK Munagala, JC Burnett Jr, MM Redfield - Current problems in cardiology, 2004 - Elsevier
Within the last five years, assay systems for measurement of plasma levels of brain
natriuretic peptide (BNP) have been approved as a diagnostic aid for heart failure (HF) …

Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance

Z Abassi, T Karram, S Ellaham, J Winaver… - Pharmacology & …, 2004 - Elsevier
The natriuretic peptide family consists of at least 3 structurally similar peptides: atrial
natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide …

Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure

DW Kitzman, WC Little, PH Brubaker, RT Anderson… - Jama, 2002 - jamanetwork.com
ContextMany older patients with symptoms of congestive heart failure have a preserved left
ventricular ejection fraction (LVEF). However, the pathophysiology of this disorder …

N-terminal–pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients

P Bettencourt, A Azevedo, J Pimenta, F Friões… - Circulation, 2004 - Am Heart Assoc
Background—Heart failure (HF) is responsible for a huge burden in hospital care. Our goal
was to evaluate the value of N-terminal–pro-brain natriuretic peptide (NT-proBNP) in …

[图书][B] Brenner & Rector's the kidney

K Skorecki, GM Chertow, PA Marsden, MW Taal… - 2016 - doctorlib.info
The volume of extracellular fluid (ECF) is maintained within narrow limits in normal human
subjects, despite day-to-day variations in dietary intake of salt and water over a wide range …

NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function

M Bay, V Kirk, J Parner, C Hassager, H Nielsen… - Heart, 2003 - heart.bmj.com
Objective: To evaluate whether measurements of N-terminal pro-brain natriuretic peptide
(NT-proBNP) can be used to differentiate patients with normal and reduced left ventricular …

Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress

S Koulouri, RJ Acherman, PC Wong, LS Chan… - Pediatric …, 2004 - Springer
Plasma B-type natriuretic peptide (BNP) has been reported to be helpful in differentiating
cardiac from pulmonary etiologies of dyspnea in adults. We investigated whether BNP …

Natriuretic peptides for the detection of diastolic dysfunction and heart failure with preserved ejection fraction—a systematic review and meta-analysis

S Remmelzwaal, AJ van Ballegooijen, LJ Schoonmade… - BMC medicine, 2020 - Springer
Background An overview of the diagnostic performance of natriuretic peptides (NPs) for the
detection of diastolic dysfunction (DD) and heart failure with preserved ejection fraction …

NT‐proBNP and BNP: biomarkers for heart failure management

P Bettencourt - European journal of heart failure, 2004 - Wiley Online Library
Guidelines for the pharmacological treatment of heart failure (HF) are based on results from
large clinical trials demonstrating benefit. State of the art pharmacological management of …

Physiological, pathological, pharmacological, biochemical and hematological factors affecting BNP and NT-proBNP

CM Balion, P Santaguida, R McKelvie, SA Hill… - Clinical …, 2008 - Elsevier
OBJECTIVES:: To gain a better understanding of the scope and breadth of factors
associated with the B-type natriuretic peptides. DESIGN AND METHODS:: Databases were …